Search - tctmd.com

Displaying 621 - 640 of 732

Sort: Relevancy | Date

Presentation ACC 2012

Long-Term Outcomes Following Transcatheter Aortic Valve Implantation: Insights on Prognostic Factors and Valve Durability from the Canadian Multicenter Experience

Presenter: Josep Rod?s-Cabau

March 24, 2012

Presentation ACC 2012

First Pharmacogenomic Analysis Using Whole Exome Sequencing to Identify Novel Genetic Determinants of Clopidogrel

Presenter: Matthew Price

March 24, 2012

Presentation ACC 2012

Economic Impact of Transradial Percutaneous Coronary Intervention

Presenter: David Safley

March 24, 2012

Presentation ACC 2012

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Presenter: Robert A. Byrne

March 24, 2012

News Conference News ACC 2012

Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation

March 24, 2012

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

News Conference News

TEST - COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

April 10, 2001

Presentation

test 2 slide - server migration

September 09, 2000

Video

» Interview

Beyond the Data: The ALIGN-AR Trial

April 18, 2025

Video

» Interview

Beyond the Data: The SOUL Trial

April 4, 2025

Video

» Interview

ACC 2025 Conference Wrap-Up

April 2, 2025

Video

» Interview

ACC 2025 Day 3 Wrap-Up

March 31, 2025

Video

» Interview

Beyond the Data: Ischemia in Women - The WARRIOR Trial

March 30, 2025

Video

» Interview

ACC 2025 Day 2 Wrap-Up

March 30, 2025

Video

» Interview

Beyond the Data: PROTECT-TAVI

March 29, 2025

Video

» Interview

ACC 2025 Day 1 Wrap-Up

March 29, 2025

Conference ACC 2025

ACC 2025

Chicago, Illinois

March 29, 2025

March 31, 2025

Video

» Interview

Beyond the Data: REDUCE-AMI

April 17, 2024

Advertisement

Long-Term Outcomes Following Transcatheter Aortic Valve Implantation: Insights on Prognostic Factors and Valve Durability from the Canadian Multicenter Experience

First Pharmacogenomic Analysis Using Whole Exome Sequencing to Identify Novel Genetic Determinants of Clopidogrel

Economic Impact of Transradial Percutaneous Coronary Intervention

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

TEST - COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

test 2 slide - server migration

Beyond the Data: The ALIGN-AR Trial

Beyond the Data: The SOUL Trial

ACC 2025 Conference Wrap-Up

ACC 2025 Day 3 Wrap-Up

Beyond the Data: Ischemia in Women - The WARRIOR Trial

ACC 2025 Day 2 Wrap-Up

Beyond the Data: PROTECT-TAVI

ACC 2025 Day 1 Wrap-Up

ACC 2025

Beyond the Data: REDUCE-AMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content